Experience Matters
Providing expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia.
Welcome to Lucid Health Consulting
With over 30 years of Health Economics, Pricing & Reimbursement, Strategic Market Access and Health Technology Assessment experience, we have helped many organisations navigate the complexities of the Australian regulatory environment and achieve market access.
We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.
Let us show you how our strategic approach and team experience can help you achieve market access in Australia.
How we can help your business?
What’s New
Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.
AusMedtech 2024
AusMedtech 2024 Just over two weeks to go until AusMedtech 2024, hosted by AusBiotech, in Adelaide, on 22-23 May. It’s not too late to register for AusMedtech 2024 where industry leaders, healthcare professionals, and tech enthusiasts converge to explore the latest...
Unlocking the Power of Social Media for Real-World Evidence in Healthcare
Unlocking the Power of Social Media for Real-World Evidence in Healthcare Our Senior Consultant of Regulatory Affairs at Lucid Health Consulting, Kathryn Williams Day, offers insightful commentary on a recent abstract published in Springer Link. Titled “Using...
Co-design of an Enhanced Consumer Engagement Process for health technology assessment in Australia.
Co-design of an Enhanced Consumer Engagement Process for health technology assessment. The Enhanced Consumer Engagement Process is one of the key commitments in the 2022-2027 strategic Agreements with Medicines Australia and the Generic and Biosimilar Medicines...
What our clients are saying.
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.